Provision of clinical pharmacy services in the home to patients recently discharged from hospital: A pilot project

Canadian Journal of Hospital Pharmacy

Volumn 61, Issue 2, 2008, Pages 103-113

  MacAulay, Stacey ^a   Saulnier, Lauza ^a   Gould, Odette ^b  

^a South East Regional Health Authority   (Canada)

^b MOUNT ALLISON UNIVERSITY   (Canada)

Author keywords

Clinical pharmacy; Home care; Hospital discharge; Medication related issues

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INFLUENZA VACCINE; LEVOTHYROXINE; ORAL ANTIDIABETIC AGENT; PARACETAMOL; VASODILATOR AGENT;

ADULT; AGED; ANEMIA; ARTICLE; CANADA; CLINICAL ARTICLE; CLINICAL PHARMACY; DRUG MONITORING; DYSLIPIDEMIA; FEMALE; GASTRITIS; GASTROESOPHAGEAL REFLUX; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEART ATRIUM FIBRILLATION; HOME CARE; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; INFLUENZA; INFLUENZA VACCINATION; INSOMNIA; ISCHEMIC HEART DISEASE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PATIENT SATISFACTION; PEPTIC ULCER; PHARMACIST; PILOT STUDY;

EID: 43149089136     PISSN: 00084123     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Romanow R (chair). Building on values. The future of health care in Canada. Saskatoon (SK): Royal Commission on the Future of Health Care in Canada; 2002 [cited 2004 Sep 131. Available from: http://www.hc-sc.gc.ca/english/care/romanow/index1.html
2. Kirby MJL (chair). The health of Canadians - the federal role. Final report on the state of the health care system in Canada. Ottawa (ON): Senate of Canada, Standing Senate Committee on Social Affairs, Science and Technology; 2002 [cited 2004 Sep 13]. Available from: http://www.parl.gc.ca/37/2/parlbus/commbus/senate/com-e/soci-e/rep-e/ repoct02vol6-e.pdf
3. Forster AJ, Clark HD, Menard A, Dupius N, Chernish R, Chandok N, et al. Adverse events among medical patients after discharge from hospital. CMAJ 2004;170(3):345-349.
4. Gray SL, Mahoney JE, Blough DK. Adverse drug events in elderly patients receiving home health services following hospital discharge. Ann Pharmacother 1999;33(11):1147-1153.
5. MacKeigan LD, Marshman JA, Kruk-Romanus D, Milovanovic DA, Jackevicius C, Naglie G, et al. Clinical pharmacy services in the home: Canadian case studies. J Am Pharm Assoc 2002;42(5):735-742.
6. Schrecengost-Kibbey MA, Ptachcinski RJ, Tuttle AL, McKaveney TP. Impact of pharmacist home visits on drug therapy [letter]. Am J Health Syst Pharm 2002;59(13):1293-1294.
7. Hsia Der E, Rubenstein LZ, Choy GS. The benefits of in-home pharmacy evaluation for older persons. J Am Geriatr Soc 1997;45(2):211-214.
8. Stewart S, Vandenbroek AJ, Pearson S, Horowitz JD. Prolonged beneficial effects of a home-based intervention on unplanned readmissions and mortality among patients with congestive heart failure. Arch Intern Med 1999;159(3):257-261.
9. Peterson GM, Fitzmaurice KD, Naunton M, Vial JH, Stewart K, Krum H. Impact of pharmacist-conclucted home visits on the outcomes of lipid-lowering drug therapy. J Clin Pharm Ther 2004;29(1):23-30.
10. Jackson SL, Peterson GM, Vial JH, Jupe DML. Improving the outcomes of anticoagulation: an evaluation of home follow-up of warfarin initiation. J Intern Med 2004;256(2)137-144.
11. Patel K, Sansgiry SS, Miller L. Pharmacist participation in home health heart-failure programs [letter]. Am J Health Syst Pharm 2003;60(21):2259-2260.
12. Williams RG, McCoy R, Frederick KR. Impact of pharmacy consultant services to a hornebound population. Consultant Pharm 1987 Nov/ Dec;:479-482.
13. Meredith S, Feldman P, Frey D, Giammarco L, Hall K, Arnold K, et al. Improving medication use in newly admitted home healthcare patients: a randomized controlled trial. J Am Geriatr Soc 2002; 50(9):1484-1491.
14. Stewart S, Pearson S, Luke CG, Horowitz JD. Effects of home-based intervention on unplanned readmissions and out-of-hospital deaths. J Am Geriatr Soc 1998;46(2):174-180.
15. Stewart S, Pearson S, Horowitz JD. Effects of a home-based intervention among patients with congestive heart failure discharged from acute care hospital. Arch Intern Med 1998;158(10):1067-1072.
16. Begley S, Livingstone C, Hodges N, Williamson V. Impact of domiciliary pharmacy visits on medication management in an elderly population. Int J Pharm Pract 1997;5:111-121.
17. Goodyer LI, Miskelly F, Milligan P. Does encouraging good compliance improve patients' clinical condition in heart failure? Br J Clin Pract 1995;49(4):173-176.
18. Sidel VW, Beizer JL, Lisi-Fazio D, Kleinmann K, Wenston J, Thomas C, et al. Controlled study of the impact of educational home visits by pharmacists to high-risk older patients. J Community Health 1990;15(3):163-174.
19. Ryan PB, Rush DR, Dodd KF, Ponder BJ, Durnell MD. Cost-effective drug regimen review program for home health care patients. Home Health Care Serv Q 1988;9(4):5-18.
20. Earp JAL, Ory MG, Strogatz DS. The effects of family involvement and practitioner home visits on the control of hypertension. Am J Public Health 1982;72(10):1146-1154.
21. Holland R, Lenaghan E, Harvey I, Smith R, Shepstone L, Lipp A, et al. Does home based medication review keep older people out of hospital? The HOMER randomised: controlled trial. BMJ 2005;330(7486):293. doi:10.1136/bmj.38338.674583.AE
22. Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med 2006;166(9):955-964.
23. Calabrese AT, Cholka K, Lenhart SE, McCarty B, Zewe G, Sunseri D, et al. Pharmacist involvement in a multidiciplinary inpatient medication education program. Am J Health Syst Pharm 2003;60(10):1012-1018.
24. Bond CA, Raehl CL, Franke T. Clinical pharmacy services and hospital mortality rates. Pharmacotherapy 1999;19(5):556-564.
25. Bond CA, Raehl CL, Franke T. Interrelationships among mortality rates, drug costs, total cost of care, and length of stay in United States hospitals: summary and recommendations for clinical pharmacy services and staffing. Pharmacotherapy 2001;21(2):129-141.
26. Bond CA, Raehl CL, Franke T. Medication errors in United States hospitals. Pharmacotherapy 2001;21(9):1023-1036.
27. Bond CA, Raehl CL, Franke T. Clinical pharmacy services, hospital pharmacy staffing, and medication errors in United States hospitals. Pharmacotherapy 2002;22(2):134-147.
28. Bond CA, Raehl CL, Patry R. Evidence-based core clinical pharmacy services in United States hospitals in 2020: services and staffing. Pharmacotherapy 2004;24(4):427-440.
29. Beney J, Bero LA, Bond C. Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes. Cochrane Database Syst Rev 2000;(3): CD000336. doi: 10.1002/ 14651858.CD000336
30. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47(3):533-543.
31. Hatoum HT, Hutchinson RA, Witte KW, Newby GP. Evaluation of the contribution of clinical pharmacists: inpatient care and cost reduction. Drug Intell Clin Pharm 1988;22(3):252-259.
32. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353(5):487-497.
33. Young C, editor. Clinical evidence. London (UK): BMJ Publishing Group; 2006.
34. Safer Healthcare Now! Getting started kit: medication reconciliation prevention of adverse drug events. How-to guide. Toronto (ON): Institute for Safe Medication Practices, Canadian Patient Safety Institute; 2007 May.
35. Patient safety goals and ROPs [Internet]. Ottawa (ON): Canadian Council on Health Services Accreditation; 2007 [cited 2007 June 25]. Available from: http://www.cchsa.ca/default.aspx?page=139